Should I Buy OFRM? OFRM 2026 Analysis

Should You Buy Once Upon A Farm PBC (OFRM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

21.000

1 Day change

-0.24%

52 Week Range

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: there are no active Intellectia buy signals, and there’s not enough post-IPO trading/price data provided to confirm a favorable entry.
The only clear driver is the IPO event itself; without confirmed trading levels, support/resistance, or valuation metrics, the risk/reward is not attractive for an immediate buy.
Neutral hedge fund/insider activity provides no “smart money” confirmation to step in aggressively.

Technical Analysis

Stock trend/price history: No data available for trend analysis, so trend direction, momentum, and key levels (support/resistance) cannot be validated.
Market context: broader market is risk-off (S&P 500 -1.33%), which often pressures new/early listings and high-multiple consumer growth stories.
Intellectia Proprietary Trading Signals
AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.
Trading trends: Hedge funds neutral (no significant last-quarter trend); insiders neutral (no significant last-month trend).

Positive Catalysts

- IPO catalyst: planned raise of ~$198M via 11M shares at $17–$19 (midpoint valuation ~$811M) can attract attention/liquidity.
- Sector tailwind: positioned in organic baby food (growth category).
- Distribution scale: products in 3,200+ retail stores.
- DTC/online strength: ~40% of sales from online channels (potentially supports higher growth and better customer retention).

Neutral/Negative Catalysts

- Event risk around IPO pricing and early trading: high volatility is common and can produce unfavorable entries for impatient buyers.
- Valuation support not provided: no valuation data (multiples, profitability, cash flow) to judge whether IPO pricing is compelling.
- Limited financial detail: only sales figure given; no margin, earnings, or cash flow context to confirm quality of growth.
- Weak tape today (S&P 500 down) can reduce appetite for new issues/growth consumer names.

Financial Performance

Latest period provided is FY ending June 30, 2025 (FY2025): reported ~$202M in sales.
Growth trend: described as “strong growth” in the organic baby food sector, but no quarter-by-quarter figures, profitability, or cash flow data were provided to validate operating leverage.
Financial snapshot feed error: “list index out of range,” so key quarterly metrics (revenue growth %, gross margin, EBITDA, net income) are unavailable.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating/price target trend provided (likely limited/none due to being pre-IPO or newly covered).
Wall Street pros view (inferred from deal/news context): attractive category + scaling distribution + meaningful online mix.
Wall Street cons view (key missing checks): unclear profitability and valuation support; IPO execution risk; limited disclosed fundamentals in the provided data.

0 Analyst Rating

Wall Street analysts forecast OFRM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFRM is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 21.050

Low

Averages

High